SUBSCRIBE
SUBSCRIBE
News   Drug Development

Antigenics Inc. (New York) Cancer Vaccine Study Shows Mixed Results

February 20, 2008 | 
1 min read
Feb 20 (Reuters) - Antigenics Inc said a late-stage trial of its cancer vaccine, Oncophage, in the treatment of metastatic melanoma, a serious form of skin cancer, did not meet its primary goal of overall survival.
Clinical research Phase III
MORE ON THIS TOPIC
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
October 23, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Facade of Moderna's building in Massachusetts
Vaccines
Moderna Scraps CMV Vaccine After Phase III Fail
October 23, 2025
 · 
3 min read
 · 
Tristan Manalac
Museum island on Spree river and Alexanderplatz TV tower in center of Berlin, Germany
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
October 22, 2025
 · 
4 min read
 · 
Tristan Manalac
Deviation from the plan, path or norms. Choosing an alternative way, changing the plans and flexibility.
Obesity
Terns Turns Away From Obesity Pill After ‘Uncompetitive’ Phase II Profile
October 22, 2025
 · 
2 min read
 · 
Tristan Manalac